selenodiglutathione has been researched along with Mouth Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
El-Bayoumy, K; Fleming, J; Ghose, A; Harrison, PR | 1 |
Fleming, J; Ghose, A; Harrison, PR | 1 |
1 review(s) available for selenodiglutathione and Mouth Neoplasms
Article | Year |
---|---|
Molecular mechanisms of cancer prevention by selenium compounds.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Disease Models, Animal; Fas Ligand Protein; Glutathione; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; Membrane Glycoproteins; Mitogen-Activated Protein Kinase Kinases; Mouth Neoplasms; Organoselenium Compounds; Selenium Compounds; Tumor Cells, Cultured | 2001 |
1 other study(ies) available for selenodiglutathione and Mouth Neoplasms
Article | Year |
---|---|
Enhanced sensitivity of human oral carcinomas to induction of apoptosis by selenium compounds: involvement of mitogen-activated protein kinase and Fas pathways.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Enzyme Induction; Fas Ligand Protein; Glutathione; Growth Inhibitors; HeLa Cells; Humans; MAP Kinase Signaling System; Membrane Glycoproteins; Mice; Mitogen-Activated Protein Kinases; Mouth Mucosa; Mouth Neoplasms; Organoselenium Compounds; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Signal Transduction | 2001 |